Clinical Trials Directory

Trials / Unknown

UnknownNCT02247622

Telomere Length and Other Parameters of Telomere Dysfunction in PSC and Colitis

Primary Sclerosing Cholangitis Telomere Length

Status
Unknown
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
Meir Medical Center · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

PSC is a chronic cholestatic disorder. The investigators intend to study some telomere parameters and telomere length in order to predict a premalignant state.

Detailed description

Primary sclerosing cholangitis (PSC) and colitis are chronic inflammatory disorders with malignant potential. Telomerase is an enzyme complex that lengthens telomeres and has enhanced expression in numerous malignancies. In this study, we evaluated the telomerase gene copy number, telomere length, cells in senescence, aneuploidy and additional parameters of telomere dysfunction from peripheral blood lymphocytes of patients.

Conditions

Timeline

Start date
2012-02-01
Primary completion
2014-09-01
Completion
2014-09-01
First posted
2014-09-25
Last updated
2014-09-25

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT02247622. Inclusion in this directory is not an endorsement.